tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Neurizon Therapeutics Updates Constitution to Support Strategic Focus
Company AnnouncementsNeurizon Therapeutics Updates Constitution to Support Strategic Focus
7d ago
Neurizon Therapeutics Announces AGM Results and Reaffirms Commitment to ALS Treatment
PremiumCompany Announcements
Neurizon Therapeutics Announces AGM Results and Reaffirms Commitment to ALS Treatment
14d ago
Neurizon Therapeutics Outlines Future Strategies Amid Uncertainties
PremiumCompany Announcements
Neurizon Therapeutics Outlines Future Strategies Amid Uncertainties
14d ago
Neurizon Therapeutics Advances Towards Commercialization with Strategic Developments
PremiumCompany Announcements
Neurizon Therapeutics Advances Towards Commercialization with Strategic Developments
14d ago
Neurizon Strengthens Board with Elanco Executive Appointment
PremiumCompany Announcements
Neurizon Strengthens Board with Elanco Executive Appointment
14d ago
Neurizon Therapeutics Issues New Shares to Support ALS Drug Development
PremiumCompany AnnouncementsNeurizon Therapeutics Issues New Shares to Support ALS Drug Development
1M ago
Neurizon Therapeutics Limited Applies for Quotation of Securities on ASX
Premium
Company Announcements
Neurizon Therapeutics Limited Applies for Quotation of Securities on ASX
1M ago
Neurizon Therapeutics Updates on Q1 FY2026 Progress and Financial Strength
Premium
Company Announcements
Neurizon Therapeutics Updates on Q1 FY2026 Progress and Financial Strength
1M ago
Neurizon Therapeutics Advances ALS Drug Development with Key Milestones
PremiumCompany Announcements
Neurizon Therapeutics Advances ALS Drug Development with Key Milestones
1M ago
Neurizon Therapeutics Announces Hybrid AGM Amid Digital Transition
PremiumCompany Announcements
Neurizon Therapeutics Announces Hybrid AGM Amid Digital Transition
2M ago
Neurizon Secures Australian Patent for NUZ-001, Strengthening Global IP Portfolio
PremiumCompany Announcements
Neurizon Secures Australian Patent for NUZ-001, Strengthening Global IP Portfolio
2M ago
Neurizon Therapeutics to Host Q1 FY2026 Shareholder Update Webinar
PremiumCompany Announcements
Neurizon Therapeutics to Host Q1 FY2026 Shareholder Update Webinar
2M ago
Neurizon Therapeutics to Present Key ALS Research at 2025 NEALS Meeting
PremiumCompany AnnouncementsNeurizon Therapeutics to Present Key ALS Research at 2025 NEALS Meeting
2M ago
Neurizon Therapeutics Announces Proposed Securities Issue
Premium
Company Announcements
Neurizon Therapeutics Announces Proposed Securities Issue
2M ago
Neurizon Therapeutics Expands U.S. Market Presence with OTCQB Listing
Premium
Company Announcements
Neurizon Therapeutics Expands U.S. Market Presence with OTCQB Listing
2M ago
FDA Clears Path for Neurizon’s ALS Drug NUZ-001 in Pivotal Trial
PremiumCompany Announcements
FDA Clears Path for Neurizon’s ALS Drug NUZ-001 in Pivotal Trial
2M ago
Neurizon Therapeutics Issues Unquoted Equity Securities for Employee Incentives
PremiumCompany Announcements
Neurizon Therapeutics Issues Unquoted Equity Securities for Employee Incentives
2M ago
Neurizon Therapeutics Expands Funding with Share Issuance
PremiumCompany Announcements
Neurizon Therapeutics Expands Funding with Share Issuance
3M ago
Neurizon Therapeutics to Quote New Securities on ASX
PremiumCompany Announcements
Neurizon Therapeutics to Quote New Securities on ASX
3M ago
Neurizon Secures R&D Tax Incentive for NUZ-001 Development
PremiumCompany AnnouncementsNeurizon Secures R&D Tax Incentive for NUZ-001 Development
3M ago
Neurizon Therapeutics Announces Proposed Securities Issue
Premium
Company Announcements
Neurizon Therapeutics Announces Proposed Securities Issue
3M ago
Neurizon Therapeutics Secures $5 Million to Advance ALS Treatment Initiatives
Premium
Company Announcements
Neurizon Therapeutics Secures $5 Million to Advance ALS Treatment Initiatives
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >